LOSS OF CD20 ANTIGEN EXPRESSION AFTER RITUXIMAB THERAPY OF CD20 POSITIVE B-CELL LOW-GRADE NON HODGKIN LYMPHOMA

Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис: http://hdl.handle.net/20.500.12188/11649

DC Field	Value	Language
dc.contributor.author	Svetlana Stankovikc	en_US
dc.date.accessioned	2021-04-05T12:11:56Z	-
dc.date.available	2021-04-05T12:11:56Z	-
dc.date.issued	2013	-
dc.identifier.uri	http://hdl.handle.net/20.500.12188/11649	-
dc.language.iso	en	en_US
dc.publisher	Turkish Society of Hematology	en_US
dc.subject	CD20 antigen	en_US
dc.subject	Rituximab	en_US
dc.subject	low-grade NHL	en_US
dc.title	LOSS OF CD20 ANTIGEN EXPRESSION AFTER RITUXIMAB THERAPY OF CD20 POSITIVE B-CELL LOW-GRADE NON HODGKIN LYMPHOMA	en_US
dc.type	Proceeding article	en_US
dc.relation.conference	4-th International Congress on Leukemia-Lymphoma-Myeloma, Istanbul, May 22-25, 2013	en_US
item.grantfulltext	open	-
item.fulltext	With Fulltext	-
crisitem.author.dept	Faculty of Medicine	-
Appears in Collections:	Faculty of Medicine: Conference papers